Coverage
-
December 19, 2018
New York's $600 million fee on the sale of opioids into the state unconstitutionally prohibits pharmaceutical companies from passing the cost onto consumers, a federal judge said Wednesday in halting payments to the state ahead of a Jan. 1 deadline.
4 other articles on this case.
View all »